|Security||AVGR / Avinger, Inc. (053734109)|
|Industry||Surgical and Medical Instruments and Apparatus|
|Institutional Shares||952,253 - 8.24%|
|Common Shares Outstanding||11,552,052 shares (as of 2018-06-30)|
|Institutional Value||$ 5,362,000 USD|
Institutional Stock Ownership and Shareholders
Avinger, Inc. (NASDAQ:AVGR) has 9 institutional investors and shareholders that have
filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 952,253 shares.
Largest shareholders include
BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., BlackRock Investment Management, LLC, R&F Capital Advisors LP, Numeric Investors Llc, Ameriprise Financial Inc, BlackRock Advisors LLC, Integrated Wealth Counsel, Llc, and Meeder Asset Management Inc.
Avinger, Inc. (NASDAQ:AVGR) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.
|ROBERTSON STEPHENS ADVISORS LLC||33,820||0||-100.00||64||0||-100.00|
|BlackRock Investment Management, LLC||85,851||85,851||0.00||410||318||-22.44|
|AMERIPRISE FINANCIAL INC||12,025||20|
|NUMERIC INVESTORS LLC||14,600||14,600||0.00||28||7||-75.00|
|BlackRock Institutional Trust Company, N.A.||160,907||213,922||32.95||768||792||3.13|
|INTEGRATED WEALTH COUNSEL, LLC||4,000||4,000||0.00||19||15||-21.05|
|NUMERIC INVESTORS LLC||14,600||0||-100.00||6||0||-100.00|
|MEEDER ASSET MANAGEMENT INC||1,046||1,179||12.72||1||1,969||196,800.00|
|BlackRock Advisors LLC||7,088||7,534||6.29||34||28||-17.65|
|BlackRock Fund Advisors||496,183||582,483||17.39||2,367||2,155||-8.96|
|R&F Capital Advisors LP||30,659||58|
2017-11-10 - Asif
Avinger is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease, or PAD. Patients with PAD have a build-up of plaque in the arteries that supply blood to areas away from the heart, particularly the pelvis and legs. The company's mission is to dramatically improve the treatment of vascular disease through the introduction of products based on its Lumivascular platform, the only intravascular image-guided system available in this market. The company manufacture and sell a suite of products in the United States and select international markets. The company's current products include its Lightbox imaging console, as well as its Wildcat, Kittycat 2, and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion, or CTO, and Pantheris, its image-guided atherectomy ...
Related News Stories
Discussion: Share price of Viking Therapeutics (VKTX) has moved up 7% on average volume ahead of mid-stage data readout of its candidate VK2809. The anticipated trial data is indicated in patients with primary hypercholesterolemia and non-alcoholic fatty liver disease (NAFLD). The candidate has a similar mechanism to Madrigal’s (NASDAQ:MDGL) MGL-3196. Viking had a June breakout connected to Madrigal’s successful mid-stage trial results. (16-4)
Greetings. And welcome to the Avinger’s Second Quarter 2018 Earnings Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] (1-0)
The bioscience market logged further gains for the second consecutive day this week. Many equities under our coverage continued to move northbound. (75-1)
Greetings and welcome to Avinger’s 2018 First Quarter Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] I’ll remind you that this conference is being recorded. (62-5)
as of ET